AR057123A1 - Composicion farmaceutica estable que contiene una pirimidina-sulfamida - Google Patents
Composicion farmaceutica estable que contiene una pirimidina-sulfamidaInfo
- Publication number
- AR057123A1 AR057123A1 ARP060103943A ARP060103943A AR057123A1 AR 057123 A1 AR057123 A1 AR 057123A1 AR P060103943 A ARP060103943 A AR P060103943A AR P060103943 A ARP060103943 A AR P060103943A AR 057123 A1 AR057123 A1 AR 057123A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- sulfamide
- pyrimidine
- composition containing
- stable pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- GZRPWFCHDLJSDX-UHFFFAOYSA-N pyrimidine;sulfamide Chemical compound NS(N)(=O)=O.C1=CN=CN=C1 GZRPWFCHDLJSDX-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000000877 morphologic effect Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 abstract 1
- 239000007884 disintegrant Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000000314 lubricant Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Reivindicacion 1: Una composicion farmacéutica que comprende: a) un compuesto de la formula (1), o una sal, solvato, hidrato o forma morfologica farmacéuticamente aceptable de éste, b) relleno, c) un desintegrante, d) un agente tensoactivo, y e) un lubricante. Reivindicacion 16: El uso de un compuesto de la formula (1) como se define en la reivindicacion 1, o una sal, un solvato, un hidrato o una forma morfologica de éste, para la preparacion de un medicamento, para ser utilizado en el tratamiento de hipertension arterial pulmonar.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP9903532 | 1999-05-22 | ||
| US09/573,504 US6316453B1 (en) | 1999-05-22 | 2000-05-18 | Aqueous pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR057123A1 true AR057123A1 (es) | 2007-11-14 |
Family
ID=26070369
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060103943A AR057123A1 (es) | 1999-05-22 | 2006-09-11 | Composicion farmaceutica estable que contiene una pirimidina-sulfamida |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6316453B1 (es) |
| EP (1) | EP1060749B1 (es) |
| JP (1) | JP4632385B2 (es) |
| AR (1) | AR057123A1 (es) |
| AT (1) | ATE235255T1 (es) |
| CA (1) | CA2308660C (es) |
| DE (1) | DE60001768T2 (es) |
| DK (1) | DK1060749T3 (es) |
| ES (1) | ES2195818T3 (es) |
| NZ (1) | NZ504671A (es) |
| PT (1) | PT1060749E (es) |
| ZA (1) | ZA200002318B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7528065B2 (en) * | 2006-01-17 | 2009-05-05 | International Business Machines Corporation | Structure and method for MOSFET gate electrode landing pad |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW313568B (es) * | 1994-12-20 | 1997-08-21 | Hoffmann La Roche | |
| DK0897914T3 (da) * | 1997-08-19 | 2004-09-27 | Hoffmann La Roche | Fremgangsmåde til fremstilling af 2,5-disubstituerede pyridiner |
-
2000
- 2000-05-11 ZA ZA200002318A patent/ZA200002318B/xx unknown
- 2000-05-16 AT AT00110425T patent/ATE235255T1/de active
- 2000-05-16 DK DK00110425T patent/DK1060749T3/da active
- 2000-05-16 PT PT00110425T patent/PT1060749E/pt unknown
- 2000-05-16 EP EP00110425A patent/EP1060749B1/en not_active Expired - Lifetime
- 2000-05-16 DE DE60001768T patent/DE60001768T2/de not_active Expired - Lifetime
- 2000-05-16 ES ES00110425T patent/ES2195818T3/es not_active Expired - Lifetime
- 2000-05-17 CA CA002308660A patent/CA2308660C/en not_active Expired - Fee Related
- 2000-05-18 US US09/573,504 patent/US6316453B1/en not_active Expired - Lifetime
- 2000-05-19 NZ NZ504671A patent/NZ504671A/en not_active IP Right Cessation
- 2000-05-19 JP JP2000148318A patent/JP4632385B2/ja not_active Expired - Fee Related
-
2006
- 2006-09-11 AR ARP060103943A patent/AR057123A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2308660C (en) | 2008-08-12 |
| JP4632385B2 (ja) | 2011-02-16 |
| EP1060749A1 (en) | 2000-12-20 |
| JP2001002564A (ja) | 2001-01-09 |
| PT1060749E (pt) | 2003-08-29 |
| NZ504671A (en) | 2001-11-30 |
| DK1060749T3 (da) | 2003-06-23 |
| ATE235255T1 (de) | 2003-04-15 |
| EP1060749B1 (en) | 2003-03-26 |
| DE60001768D1 (de) | 2003-04-30 |
| CA2308660A1 (en) | 2000-11-22 |
| DE60001768T2 (de) | 2003-10-16 |
| ZA200002318B (en) | 2000-11-16 |
| ES2195818T3 (es) | 2003-12-16 |
| US6316453B1 (en) | 2001-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
| UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
| AR035482A1 (es) | Uso de un compuesto de cianoquinolina para la manufactura de un medicamento para tratar o inhibir polipos colonicos | |
| BR0107869A (pt) | Composições farmacêuticas eletrogiradas | |
| BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
| BR0115910A (pt) | Compostos orgânicos | |
| PE20001032A1 (es) | Composiciones y metodos para tratar enfermedades pulmonares | |
| AR038535A1 (es) | Formulaciones farmaceuticas de agentes antineoplasicos y procesos para prepararlos y usarlos | |
| FR2805818B1 (fr) | Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant | |
| ES2190075T3 (es) | Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico. | |
| AR006598A1 (es) | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" | |
| SE9900961D0 (sv) | Novel compounds | |
| JP2005520779A5 (es) | ||
| ATE248187T1 (de) | Echinocandin-kohlenhydrate-komplexe | |
| SE9904413D0 (sv) | Comminuted form | |
| AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
| GEP20043162B (en) | Derivatives of Isosorbid Mononitrate, Utilization as Vasodilator Agents with Reduced Tolerance | |
| SE8804628D0 (sv) | New compounds | |
| LV10267A (lv) | Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai | |
| UY26459A1 (es) | 3,4-dihidroquinazolinas 5,6-disustituidas | |
| AR057123A1 (es) | Composicion farmaceutica estable que contiene una pirimidina-sulfamida | |
| AR043016A2 (es) | Un compuesto antimigranico eletriptan y composicion farmaceutica que lo contiene | |
| BE2016C017I2 (es) | ||
| SE0000303D0 (sv) | Novel compounds | |
| MXPA04005033A (es) | Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |